abstract |
The invention relates to a compound of Formula (I) wherein, R 1 and R 2 independently are selected from the group consisting of optionally substituted (6-10C)aryl and (1-5C)heteroaryl groups. The compounds can be used in pharmaceutical compositions, in particular in the treatment of cancer. |